Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • The New Criterion: rural stocks that won’t go to water
    • Opinion

    The New Criterion: rural stocks that won’t go to water

    Water is the staff of life – and no more so for ASX listed stocks that depend on water rights to grow their crops or else trade them for gain without tilling a single sod. What side should investors be on in the great water debate: the suppliers or the users? As with every aspect

    Read More
    Public
  • CSR annual report – expected vs actual
    • Opinion

    CSR annual report – expected vs actual

    CSR Limited CSR Limited (ASX: CSR) this morning has reported a 10 percent drop in statutory NPAT from continuing operations and a 5 percent drop in revenue. CSR stated that this reflected a slow-down in residential construction. Statutory NPAT was up strongly, which reflected a loss from discontinued operations in the previous period. The business

    Read More
    Public
  • Harris Tech report $1m revenue from opportunistic sanitary sales
    • News

    Harris Tech report $1m revenue from opportunistic sanitary sales

    When Harris Technology (ASX: HT8) started selling sanitary products amidst the global demand surge brought upon by the coronavirus pandemic, they estimated Q4 sales of around $400,000. Today they reported they have sold more than $1 million worth of their Pro-Hygiene products in April alone. Whilst IT and electronics are Harris Technology’s flagship products, they

    Read More
    Public
  • ASX IPO May: Intelicare
    • News

    ASX IPO May: Intelicare

    For the second consecutive month, only one company is set to list in May, indicating that companies are still feeling reluctant to even attempt a public debut in the current economic environment.  Artificial intelligence (AI) tech company, Intelicare (Proposed ASX: ICR), is looking to raise a modest $5.5m at an offer price of $0.20. Intelicare

    Read More
    Public
  • Testing confirms EcoGraf can purify low value graphite for li-ion battery use
    • News

    Testing confirms EcoGraf can purify low value graphite for li-ion battery use

    The world may not have enough spherical graphite to meet demand for the growing lithium-ion battery market, but we may not need it with testing confirming that EcoGraf (ASX: EGR) can produce high purity graphite from low value by-products.  The EcoGraf(™) Process has been undergoing rigorous testing in Europe over the past 18 months with

    Read More
    Public
  • Top podiatry operator Healthia, makes big push in Victoria with 12 clinic acquisition
    • News

    Top podiatry operator Healthia, makes big push in Victoria with 12 clinic acquisition

    Allied health services group Healthia (ASX: HLA) has continued its expansion as Australia’s largest operator podiatry clinics, today announcing the acquisition of 12 clinics in Victoria to significantly expand its healthcare offerings in the State.  Secured for a total consideration of $5 million, the 12 new clinics are forecast to deliver Healthia with $4.4m revenue

    Read More
    Public
  • «
  • ‹
  • 611
  • 612
  • 613
  • 614
  • 615
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.